Intra-Cellular Therapies, Inc.
ITCI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $307 | $148 | $149 | $92 |
| Short-Term Investments | $694 | $350 | $443 | $320 |
| Receivables | $167 | $114 | $75 | $20 |
| Inventory | $26 | $12 | $24 | $8 |
| Other Curr. Assets | $114 | $44 | $47 | $27 |
| Total Curr. Assets | $1,307 | $668 | $738 | $467 |
| Property Plant & Equip (Net) | $15 | $15 | $17 | $23 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $45 | $46 | $0 | $0 |
| Total NC Assets | $60 | $60 | $17 | $23 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,367 | $728 | $755 | $490 |
| Liabilities | – | – | – | – |
| Payables | $26 | $11 | $10 | $9 |
| Short-Term Debt | $4 | $4 | $5 | $7 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $175 | $108 | $68 | $38 |
| Total Curr. Liab. | $206 | $124 | $83 | $53 |
| LT Debt | $13 | $13 | $15 | $18,694 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | -$18,675 |
| Total NC Liab. | $13 | $13 | $15 | $19 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $17 | $20 | $25 |
| Total Liabilities | $218 | $137 | $99 | $72 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,692 | -$1,617 | -$1,477 | -$1,221 |
| AOCI | $0 | $0 | -$4 | -$0 |
| Other Equity | $2,840 | $2,208 | $2,138 | $1,639 |
| Total Equity | $1,148 | $591 | $656 | $418 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,367 | $728 | $755 | $490 |
| Net Debt | -$290 | -$131 | -$129 | $18,608 |